Terms ending in 2034
Every in-force patent on Abbott Laboratories's record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US D837,053 | Container In force · High confidence | Abbott Laboratories | In force | High confidence | |
| US D837,401 | Carrier for Use in a Diagnostic Analyzer In force · High confidence | Abbott Laboratories | In force | High confidence | |
| US 10,444,242 | Detection Methods Employing HCV Core Lipid and DNA Binding Domain Monoclonal Antibodies In force · Medium confidence | Abbott Laboratories | In force | Medium confidence | |
| US 10,398,715 | Methods for Increasing Brain Functionality Using 2-Fucosyl-LACTOSE In force · High confidence | Abbott Laboratories | In force | High confidence | |
| US 11,067,485 | Automated Smear Making Apparatus In force · High confidence | Abbott Laboratories | In force | High confidence | |
| US 9,970,045 | Cellular Analysis of Body Fluids In force · High confidence | Abbott Laboratories | In force | High confidence | |
| US D838,613 | Diagnostic Analyzer In force · High confidence | Abbott Laboratories | In force | High confidence | |
| US D840,048 | Diagnostic Analyzer In force · High confidence | Abbott Laboratories | In force | High confidence | |
| US 9,844,532 | Infant Nutritional Product with RRR Alpha-Tocopherol In force · High confidence | Abbott Laboratories | In force | High confidence | |
| US 10,328,049 | Infant Nutritional Product with RRR Alpha-Tocopherol In force · Medium confidence | Abbott Laboratories | In force | Medium confidence | |
| 34 more term ends in 2034 · Pro | |||||
10 of 44 patents shown. Soonest term end first, then patent number.
Pro members see all 44.
34 of these are in force and held by Abbott Laboratories.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.